| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |